|
Patient reported outcomes in NRG Oncology/RTOG 0938, evaluating two ultrahypofractionated regimens (UHR) for prostate cancer (CaP). |
|
|
No Relationships to Disclose |
|
|
Research Funding - Genentech/Roche (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Sanofi |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Medivation/Astellas |
|
|
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property - Patents Held in name on Lee Ponsky-unrelated to study |
|
|
Employment - Kaiser Permanente |
|
|
Consulting or Advisory Role - Teva |
Research Funding - Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Yao Technologies (I) |
Honoraria - Astellas Pharma; Bayer; Ferring; Janssen |
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen |
Research Funding - Abbvie (Inst); Janssen (Inst) |
Travel, Accommodations, Expenses - Bayer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Accuray; Astellas Pharma; Bayer; Ferring; Genomic Health; Millennium |
Consulting or Advisory Role - Accuray; Ferring; GenomeDx |
Speakers' Bureau - Varian Medical Systems |
Research Funding - Janssen Oncology |
Patents, Royalties, Other Intellectual Property - Elsevier; Springer |
Expert Testimony - Ferring |
Travel, Accommodations, Expenses - Ferring |
|
|
No Relationships to Disclose |
|
|
Employment - Arizona Oncology Services Physicians |
|
Research Funding - Bayer (Inst); Cyva Technologies (Inst) |
|
|
Honoraria - Varian Medical Systems |
Consulting or Advisory Role - AstraZeneca; Bayer; Blue Earth Diagnostics; Eviti; Janssen; Medivation/Astellas; Sanofi |
Other Relationship - Caribou Publishing |
|
|
Consulting or Advisory Role - Best Doctors, Inc |
Patents, Royalties, Other Intellectual Property - UpToDate |